These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 2420886
1. Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach. Russell JK, Hayes MP, Carter JM, Torres BA, Dunn BM, Russell SW, Johnson HM. J Immunol; 1986 May 01; 136(9):3324-8. PubMed ID: 2420886 [Abstract] [Full Text] [Related]
2. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW. J Immunol; 1985 Mar 01; 134(3):1609-18. PubMed ID: 2578513 [Abstract] [Full Text] [Related]
3. Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function. Magazine HI, Carter JM, Russell JK, Torres BA, Dunn BM, Johnson HM. Proc Natl Acad Sci U S A; 1988 Feb 01; 85(4):1237-41. PubMed ID: 2448795 [Abstract] [Full Text] [Related]
4. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group. Motté P, Alberici G, Ait-Abdellah M, Bellet D. J Immunol; 1987 May 15; 138(10):3332-8. PubMed ID: 2437187 [Abstract] [Full Text] [Related]
5. Topology of receptor binding domains of mouse IFN-gamma. Jarpe MA, Johnson HM. J Immunol; 1990 Nov 15; 145(10):3304-9. PubMed ID: 1700005 [Abstract] [Full Text] [Related]
6. Binding site on the murine IFN-gamma receptor for IFN-gamma has been identified using the synthetic peptide approach. VanVolkenburg MA, Griggs ND, Jarpe MA, Pace JL, Russell SW, Johnson HM. J Immunol; 1993 Dec 01; 151(11):6206-13. PubMed ID: 8245462 [Abstract] [Full Text] [Related]
7. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma. Kwok AY, Zu X, Yang C, Alfa MJ, Jay FT. Immunology; 1993 May 01; 79(1):131-7. PubMed ID: 7685313 [Abstract] [Full Text] [Related]
8. The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. Hildreth JE, August JT. J Immunol; 1985 May 01; 134(5):3272-80. PubMed ID: 2580022 [Abstract] [Full Text] [Related]
9. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor. Sheehan KC, Calderon J, Schreiber RD. J Immunol; 1988 Jun 15; 140(12):4231-7. PubMed ID: 2453573 [Abstract] [Full Text] [Related]
10. Antibodies against a peptide representative of a conserved region of human IFN-alpha. Differential effects on the antiviral and antiproliferative effects of IFN. Barasoain I, Portolés A, Aramburu JF, Rojo JM. J Immunol; 1989 Jul 15; 143(2):507-12. PubMed ID: 2738400 [Abstract] [Full Text] [Related]
11. The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma receptor. Griggs ND, Jarpe MA, Pace JL, Russell SW, Johnson HM. J Immunol; 1992 Jul 15; 149(2):517-20. PubMed ID: 1385606 [Abstract] [Full Text] [Related]
12. Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids. Leinikki PO, Calderon J, Luquette MH, Schreiber RD. J Immunol; 1987 Nov 15; 139(10):3360-6. PubMed ID: 2960733 [Abstract] [Full Text] [Related]
13. Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. Pontzer CH, Russell JK, Johnson HM. J Immunol; 1989 Jul 01; 143(1):280-4. PubMed ID: 2499630 [Abstract] [Full Text] [Related]
14. A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine. Caruso A, Tiberio L, De Rango C, Bonfanti C, Flamminio G, Gribaudo G, Monti E, Viani E, Manca N, Garotta G. J Immunol; 1993 Feb 01; 150(3):1029-35. PubMed ID: 8423329 [Abstract] [Full Text] [Related]
15. Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptides. Greenfield RS, Braslawsky GR, Kadow KF, Spitalny GL, Chace D, Bull CO, Bursuker I. J Immunol; 1993 Jun 15; 150(12):5241-51. PubMed ID: 8515057 [Abstract] [Full Text] [Related]
16. Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Szente BE, Johnson HM. Biochem Biophys Res Commun; 1994 May 30; 201(1):215-21. PubMed ID: 8198577 [Abstract] [Full Text] [Related]
17. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2. Lu J, Chuntharapai A, Beck J, Bass S, Ow A, De Vos AM, Gibbs V, Kim KJ. J Immunol; 1998 Feb 15; 160(4):1782-8. PubMed ID: 9469437 [Abstract] [Full Text] [Related]
18. Stable expression of a secreted form of the mouse IFN-gamma receptor by rat cells. Fernando LP, LeClaire RD, Obici S, Zavodny PJ, Russell SW, Pace JL. J Immunol; 1991 Jul 15; 147(2):541-7. PubMed ID: 1830066 [Abstract] [Full Text] [Related]
19. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. Wagener C, Yang YH, Crawford FG, Shively JE. J Immunol; 1983 May 15; 130(5):2308-15. PubMed ID: 6187849 [Abstract] [Full Text] [Related]
20. Recognition of two Dermatophagoides pteronyssinus-specific epitopes on antigen P1 by using monoclonal antibodies: binding to each epitope can be inhibited by serum from dust mite-allergic patients. Chapman MD, Sutherland WM, Platts-Mills TA. J Immunol; 1984 Nov 15; 133(5):2488-95. PubMed ID: 6207232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]